Skip to main content

Table 1 Some important descriptive demographic, clinical, and laboratory data of the studied diabetic and control groups

From: Health-related quality of life in a group of Egyptian children and adolescents with type 1 diabetes: relationship to microvascular complications

Variables Diabetic group
n = 60
Mean ± SD
Range
Control group
n = 60
Mean ± SD
Range
Age (years) 13.03 ± 2.78 (8–18) 12.43 ± 2.66 (8–18)
Age of onset of disease (years) 5.68 ± 2.77 (1–12)  
Disease duration (years) 7.34 ± 4.24 (1–17)  
Height (cm) 151.23 ± 10.17 (125–167) 150.00 ± 12.51 (120–172)
Weight (kg) 45.29 ± 12.54 (21–70) 42.16 ± 10.46 (22–72)
BMI (kg/m2) 19.33 ± 3.31 (13.4–27.3) 18.35 ± 2.51 (12.1–28.1)
Mean Insulin dose (IU/kg/d) 1.04 ± 0.30 (0.48–1.70)  
Systolic blood pressure (mmHg) 110.33 ± 10.73 (90–130) 104.58 ± 10.05 (90–120)
Diastolic blood pressure (mmHg) 71.75 ± 9.69 (50–90) 65.00 ± 6.57 (50–80)
MRBG (mg/dl) 214.15 ± 49.94 (105–360) 84.53 ± 9.25 (70–105)
HbAlc (%) 8.88 ± 1.56 (5.6–12.6)  
  1. SD standard deviation, IU/kg/d international unit per kilogram per day, BMI body mass index, MRBG mean random blood glucose, Mg/dl milligram per deciliter, HbAlc glycated hemoglobin A1C